Dr. Diana Santo Domingo, MD

Dr. Santo Domingo practices at Stanford Health Care Tri-Valley in Pleasanton, California, part of Stanford University.

Dr. Santo Domingo's NPI, 1437350709, was assigned on May 31, 2007. Dr. Santo Domingo graduated from St. George's University School of Medicine in 2004. Dr. Santo Domingo holds California license C168169.

Dr. Santo Domingo's primary practice is Stanford Health Care Tri-Valley, at 5555 West Las Positas Boulevard, Pleasanton, CA 94588 in Alameda County. The practice phone is (925) 847-3000.

Dr. Santo Domingo's primary practice is Stanford Health Care Tri-Valley in Pleasanton, California, part of Stanford University. The medical group on file is Berman Skin Institute. Dmand AI also links Dr. Santo Domingo to 2 more group practices and clinics and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Santo Domingo practices, 3 sites in all. Vendor and product names are available with a free account.

Dermatology is Dr. Santo Domingo's primary specialty in the NPI Registry, under taxonomy code 207N00000X. Dr. Santo Domingo is board certified in dermatology by the American Board of Dermatology. Dmand AI has Dr. Santo Domingo's licenses on file in 5 states: California, Florida, Louisiana, Texas and Ohio.

Dmand AI lists benign or precancerous skin growths among the conditions Dr. Santo Domingo treats.

CMS data shows 416 Medicare services from Dr. Santo Domingo across 8 procedure codes in 2024, for 131 Medicare patients. Medicare paid $17,040 for them. Every service was in an office.

CMS counts 131 Medicare patients who saw Dr. Santo Domingo in 2024. The largest group is 65 to 74, with 67 patients. 75% of them have high cholesterol, and 69% have high blood pressure. 31% are also on Medicaid. Their average risk score is 1.12, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Santo Domingo's median patient age at 68, with 54% women.

In 2024, Dr. Santo Domingo wrote 154 Medicare Part D claims for 89 patients. 97% of them were for generic drugs. CMS names the drug for 60 of them, across 3 drugs with 11 or more claims each, at $1,163 in total drug cost. In 2023, CMS named 66 claims across 3 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 85 out of 100 for Dr. Santo Domingo for performance year 2024, reported as part of a group. Dr. Santo Domingo accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS counts 122 procedures of removal of skin lesions by Dr. Santo Domingo, more than 76% of the clinicians it reports for that procedure.

Dmand AI links 1 paper to Dr. Santo Domingo. Dr. Santo Domingo's most frequent co-author is Jena Auerbach, DO.

CMS Open Payments shows 48 general payments to Dr. Santo Domingo from 19 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 100% of the total. Galderma Laboratories, L.P. paid the most, $149.

Dr. Santo Domingo graduated from St. George's University School of Medicine in 2004.

Dr. Santo Domingo is in network with 6 carriers, including Aetna, Blue Cross Blue Shield of Michigan and Elevance. PPO plans come from the most carriers, 6. Check the plan with the practice before a visit.